The US Food and Drug Administration has approved a heart stent specifically made for infants and young children ... days for ...

Additionally, it remains the only RSV immunization approved for pregnant individuals at 32 through 36 weeks of gestation to protect infants from birth up to 6 months of age. The FDA’s decision ...

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

The US Food and Drug Administration (FDA) has approved Hympavzi (marstacimab, Pfizer) as routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients 12 years or older ...

Common side effects include decreased neutrophils, increased glucose, fatigue, and stomatitis, affecting over 20% of patients. The Food and Drug Administration (FDA) has approved Itovebi (inavolisib) ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

The U.S. FDA recently approved FluMist as a self or caregiver ... healthcare facilities to receive the shot. In addition, many children and adults have a fear of needles, and the nasal spray ...

The FDA approval of HYMPAVZI was supported by the Phase III BASIS clinical trial. Credit: Andrey_Popov/Shutterstock. Pfizer has announced the approval of HYMPAVZI ...

Hympavzi is Pfizer's second hemophilia treatment to receive FDA approval this year ... bleeding disorders program at Cohen Children's Medical Center. The approval was based on a late-stage study ...